LifeStance Health Group, Inc.

LifeStance Health Group, Inc. Stock Forecast & Price Prediction

Live LifeStance Health Group, Inc. Stock (LFST) Price
$6.62

2

Ratings

  • Buy 1
  • Hold 0
  • Sell 1
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$6.62

P/E Ratio

-10.82

Volume Traded Today

$1.1M

Dividend

Dividends not available for LFST

52 Week High/low

9.59/4.63

LifeStance Health Group, Inc. Market Cap

$2.51B

🛑 Alert: These ten stocks could have higher potential than $LFST 🛑

Before you buy LFST you’ll want to see this list of ten stocks that have huge potential. Want to see if LFST made the cut? Enter your email below

LFST Summary

The LifeStance Health Group, Inc. (LFST) share price is expected to increase by 28.4% over the next year. This is based on calculating the average 12-month share price estimate provided by 2 stock analysts who have covered LFST. Price targets range from $7.00 at the low end to $10.00 at the high end. The current analyst consensus for LFST is a sell. Please note analyst price targets are not guaranteed and could be missed completely.

LFST Analyst Ratings

About 2 Wall Street analysts have assigned LFST 1 buy ratings, 0 hold ratings, and 1 sell ratings. This means that analysts expect LifeStance Health Group, Inc. to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on LFST. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

LFST stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

stephanie davis
Barclays

Sell

$7.0

initiatedcoverage

Jan 2, 2024
craig hettenbach
Morgan Stanley

Buy

$10.0

maintained

Nov 30, 2023
lisa gill
J.P. Morgan

Hold

$8.0

maintained

Nov 17, 2023
gary taylor
TD Cowen

Hold

$6.0

maintained

Nov 13, 2023
jamie perse
Goldman Sachs

Hold

None

maintained

Nov 8, 2023
kevin caliendo
UBS

Hold

$10.0

maintained

May 12, 2023
ricky goldwasser
Morgan Stanley

Buy

$10.0

maintained

May 11, 2023
brian tanquilut
Jefferies

Buy

$7.25

initiatedcoverage

Nov 7, 2022
stephanie wissink
Jefferies

Buy

$18.0

maintained

Apr 28, 2022
ryan daniels
William Blair

Buy

None

initiatedcoverage

Jul 6, 2021

LFST Company Information

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform, as well as offers patients care virtually through its online delivery platform or in-person at its centers in 33 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.

LFST
LifeStance Health Group, Inc. (LFST)

When did it IPO

2021

Staff Count

6,418

Country

United States

Sector/Industry

Healthcare/Medical Care Facilities

CEO

Mr. Kenneth Alan Burdick

Market Cap

$2.51B

LifeStance Health Group, Inc. (LFST) Financial Data

In 2023, LFST generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that LFST's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year

Revenue From 2023

N/A

0.00 %
From Previous Year
  • Revenue TTM $1.00B
  • Operating Margin TTM -10.2%
  • Gross profit TTM $237.0M
  • Return on assets TTM -4.3%
  • Return on equity TTM -12.6%
  • Profit Margin -18.7%
  • Book Value Per Share 3.84%
  • Market capitalisation $2.51B
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • Revenue for 2023 N/A
  • EPS this year (TTM) $-0.52

LifeStance Health Group, Inc. (LFST) Latest News

... ...

Similar Stocks to LifeStance Health Group, Inc. - LFST

🛑 Alert: These ten stocks could have higher potential than $LFST 🛑

Before you buy LFST you’ll want to see this list of ten stocks that have huge potential. Want to see if LFST made the cut? Enter your email below

...

LFST Frequently asked questions

The highest forecasted price for LFST is $10.00 from ricky goldwasser at Morgan Stanley.

The lowest forecasted price for LFST is $7.00 from stephanie davis from Barclays

The LFST analyst ratings consensus are 1 buy ratings, 0 hold ratings, and 1 sell ratings.